Active resources for money, knowledge, access, and people
We know most of them personally and can make an introduction
Investors
Octopus Ventures. A £1bn Venture Capital fund with global offices, that does Seed investments starting at around £1m and Series A around £5m. A large and dedicated medical investments team.
Oxford Capital. A Venture Capital fund based in Oxford and London, investing in most sectors with deals ranging from £0.5m-£3m. They usually aim to take around 20-25%, and their wide network of Angels act as both co-investors on larger deals and alternative investors for smaller ones (under £0.5m).
Albion Capital. A large investor with numerous funds and a long track record in medical investments, including Forward (CEP2017). Can invest from £1m to £10m+, usually for products that have just started engaging with their first paying customers.
MCo. A family office with large financial firepower, which invested in CEEK (CEP2016). Sector agnostic, with no external investors to report to, meaning it doesn’t need to rush its exits. No fixed mandate but usually needs to invest over £1m. Seeks strong Board representation.
Mercia Technologies. A leading regional investor, managing £500m in a series of smaller EIS funds across the country, with some targeting the north of England exclusively. A large medical investments team, invested in Inovus (Elliot Street, CEP2017). £50k-£5m, loans and equity.
Profounders Capital. A Venture Capital fund managing the money of successful entrepreneurs- who themselves act as advisors to investee companies. Focus on growth of tech companies, starting at around £0.75m. Takes 20-25%, between fund and the advisor co-investors.
Index Ventures. US-UK fund investing across sectors, with some telemed investments in Europe. Can invest into any size of funding round and at any stage of product development.
GV. Formerly Google Ventures, GV is the investment arm of Google. The target is later stage growth, with minimum investments around £10m. Willing to give GCP (Google Cloud) credits to some companies at earlier stages.
Voulez Capital. A fund for women entrepreneurs, investing £500k-£1m in companies that have a product ready for market. In some cases will invest before regulatory approval.
Newable. Both a platform for angel investors, and a fund in its own right. Invests £150k-£2.5m in companies with tech at their core and a management team in place.
Angels in MedCity. A programme that brings together expertise in the medical sector with angel investors, to create more understanding among the angel community about medical investments. They hold pitching events for entrepreneurs.
Angel Academe. An angel platform of mostly female angels, for companies with at least 1 woman founder. Offer £250k-£5m for S/EIS companies that already have a product and sales in their market, and a business plan that can return 10x in 3-7 years.
Cambridge Angels. An angel platform for companies seeking £50k-£500k. The money must be for growth- hiring, sales, marketing- and the market opportunity must be more than £100m.
Business Services
Shakespeare Martineau. Law firm and sponsor of the CEP. They provide lectures and mentoring throughout the year, and have been used by a number of CEP companies.
Robert P. Mollen. Bob is a very experienced corporate lawyer, medical sector mentor, and mentor on the CEP program. Writes articles about fundraising and other aspects of entrepreneurship, and has access to numerous investors and resources.
The One Off. Design and marketing agency, who lecture and mentor on the CEP and have worked with a number of CEP companies.
Bob Penney. Bob is a very experienced international business management consultant in the life science/medtech industries, with a focus on team formation, recruitment, and management. He has set up several companies and is a mentor on the CEP program, for which he runs workshops on “Using the Power of The Team To Succeed”. He currently works with three CEP companies- Inovus Medical, NeuroRepsonse, and Bromley Emergency Training & Research- and is available to help others.
Accelerators & Networks
RebelBio. 3 months residential, based in the Imperial buildings at White City. 2 intakes per year, each of 8 companies (from 500 applicants). You need to be in a team of 2 co-founders to join. Part of the SOSV network of accelerators.
NHS Innovation Accelerator. The NIA is an accelerator that sits within the NHS and takes on 12-15 companies per year. It has a special focus on uptake and adoption, helped by its close links to the Academic Health Science Networks (AHSNs), for companies with an existing and certified product. Applications open around September each year for a March start.
Tech London Advocates. A network of 6,000 tech advocates, drawn from industry, academia, thought leaders and practitioners, who provide events, mentoring, investment platforms, and other connections. There is a health tech vertical in the London network.
Public. An accelerator that helps companies engaged with or selling to the public sector. An annual batch of companies spend 6 months receiving group lectures and bespoke support, followed by help with fundraising. Generally focused on tech, and ranging from pure idea to funded company.
EIT Health. A network of health innovators backed by the EU. Provides grants, events, connections, pitching opportunities and other resources.
Entrepreneur First. A well-known and global accelerator network, in which you begin with a Form phase in which you form a team, and then enter the Launch phase in which you develop your product.
Techstars. Global accelerator program providing $120k for a mentor-led three months, with a focus on web or software companies.
Founders Factory. A 6-month Startup program and a 6-month Scale-up program, each providing money, from Brent Hoberman and Henry Lane Fox.
Med Tech Super Connector. An accelerator for products in MedTech. Can apply even without an idea, as the program puts people together. £1,000 per month stipend + £60k to use on products. Must be a Masters/PhD student at a partner institution, or a post-doc.
Seedcamp. Somewhere between an accelerator and a very hands-on investor. Provide a fixed £100k for 7.5%, as your first money, for products that are between the prototype-ready and early revenue stage.